IMAGE: Lung squamous cell carcinoma

Breaking News

Key: Meeting M      Journal J      Funder F

Showing releases 1026-1050 out of 1291.

<< < 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 > >>

Public Release: 22-Sep-2015
Journal of Urology
More men at risk for prostate cancer as a result of less regular screening
The US Preventive Services Task Force recommendation against regular prostate specific antigen (PSA) screening for prostate cancer is controversial. While it may reduce the risk of over diagnosis and overtreatment, the reduction in intermediate and high risk cancer diagnoses raises concern because of the potential for delayed diagnoses of important cancers in men who may benefit from treatment, according to investigators reporting in The Journal of Urology.

Contact: Linda Gruner
Elsevier Health Sciences

Public Release: 21-Sep-2015
Deutsches Ärzteblatt International
Breast cancer: Care in Germany
Every year, more than 70,000 women in Germany develop an invasive breast tumor. This makes breast cancer the most common tumor disease in women. The current edition of Deutsches Ärzteblatt International contains no less than three articles focusing on breast cancer.

Contact: Elke Bartholomäus
Deutsches Aerzteblatt International

Public Release: 21-Sep-2015
Health Psychology Review
Study finds targeting exercise is not the best way to reduce prolonged sitting
Targeting sitting time, rather than physical activity, is the most effective way to reduce prolonged sitting, according to the first comprehensive review of strategies designed to reduce sitting time. The research, led by the Institute of Psychiatry, Psychology & Neuroscience at King's College London, is published in the journal Health Psychology Review.

Contact: Jack Stonebridge
King's College London

Public Release: 21-Sep-2015
Journal of Medical Screening
Over 50 percent don't go for new bowel cancer test
More than half of people invited to take a new bowel cancer screening test didn't take up the opportunity -- even though it could stop them developing or dying from the disease, according to a Cancer Research UK report published today in the Journal of Medical Screening.
Cancer Research UK

Contact: Paul Thorne
Cancer Research UK

Public Release: 21-Sep-2015
Canadian Medical Association Journal
Ontario shift to family health teams leads to improved diabetes care for patients
Paying doctors differently and adding other professionals to the health team has improved diabetes care for patients in Ontario, according to a new study by researchers at St. Michael's Hospital.
Canadian Institutes of Health Research

Contact: Kendra Stephenson
St. Michael's Hospital

Public Release: 21-Sep-2015
Nature Methods
Targeting DNA
MIT biological engineers have developed a modular system of proteins that can detect a particular DNA sequence in a cell and then trigger a specific response, such as cell death.

Contact: Sarah McDonnell
Massachusetts Institute of Technology

Public Release: 21-Sep-2015
Study: Brentuximab vedotin effective, safe in elderly Hodgkin lymphoma patients
A study published online in Blood, the Journal of the American Society of Hematology, reports that bretuximab vedotin is an effective and safe first course of treatment for older Hodgkin lymphoma patients unfit for chemotherapy.

Contact: Amanda Szabo
American Society of Hematology

Public Release: 21-Sep-2015
Role of cancer-suppressing gene uncovered
University of Adelaide researchers have uncovered the role played by a gene which suppresses the development of cancer.

Contact: Professor Robert Richards
University of Adelaide

Public Release: 21-Sep-2015
Nature Communications
Scientists identify DNA alterations as among earliest to occur in lung cancer development
Working with tissue, blood and DNA from six people with precancerous and cancerous lung lesions, a team of Johns Hopkins scientists has identified what it believes are among the very earliest 'premalignant' genetic changes that mark the potential onset of the most common and deadliest form of disease.
NIH/National Cancer Institute

Contact: Catherine Gara
Johns Hopkins Medicine

Public Release: 21-Sep-2015
Frontiers in Optics: The 99th OSA Annual Meeting
Pushing the limits of lensless imaging
Using ultrafast beams of extreme ultraviolet light streaming at a 100,000 times a second, researchers from the Friedrich Schiller University Jena, Germany, have pushed the boundaries of a well-established imaging technique. The new approach could be used to study everything from semiconductor chips to cancer cells.

Contact: Rebecca Andersen
The Optical Society

Public Release: 21-Sep-2015
Molecular Biology of the Cell
Van Andel Research Institute, University of Toledo find way to combat brain cancer
Scientists at the University of Toledo Health Science Campus (UT) and Van Andel Research Institute (VARI) have discovered an innovative way that may stop the spread of the most lethal and aggressive brain cancer glioblastoma multiforme (GBM). In laboratory studies, scientists demonstrated that activating a specific family of proteins halted cancer cell migration into healthy tissue.

Contact: Beth Hinshaw-Hall
Van Andel Research Institute

Public Release: 21-Sep-2015
Journal of Developmental Origins of Health and Disease
Mice exposed to environmental chemicals may show decreased physical activity in offspring
Endocrine disruptors interfere with endocrine or hormone systems and can cause tumors, birth defects and developmental disorders in mammals. Now, a University of Missouri study suggests that female mice exposed to environmental chemicals may cause decreases in their daughter's metabolism and the amount of exercise in which they engage in later in life. These disruptors when introduced in developmental stages, are essentially creating 'couch potatoes' among female mice and could predict future metabolic complications.
National Institutes of Health

Contact: Jeff Sossamon
University of Missouri-Columbia

Public Release: 20-Sep-2015
Monitoring the microbiome in leukemia patients could reduce infections during chemotherapy
Researchers report that a patient's microbial diversity, even before they start cancer treatment, can be linked to risk of infection during induction chemotherapy. This research is presented at ASM's Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC/ICC).
MD Anderson Cancer Center

Contact: Aleea Khan
American Society for Microbiology

Public Release: 18-Sep-2015
Journal of Bone and Joint Surgery
One size doesn't fit all
Jefferson researchers identified a high risk for venous thromboembolism, or blood clots, following surgery for long-bone reconstruction in patients with metastatic cancer. They published the results in the Journal of Bone and Joint Surgery.

Contact: Gail Benner
Thomas Jefferson University

Public Release: 18-Sep-2015
Nature Communications
TSRI study identifies novel role of mitochondria in immune function
Scientists at the Scripps Research Institute have discovered a new role for an enzyme involved in cell death. Their study shows how the enzyme, called RIPK3, relays signals between the cell's mitochondria 'powerhouses' and the immune system. The new study shows that this crosstalk is important not only for launching immune responses against tumors, but also for regulating the inflammatory responses that may result in autoimmune diseases.
National Institutes of Health

Contact: Madeline McCurry-Schmidt
Scripps Research Institute

Public Release: 18-Sep-2015
PLOS Genetics
Discovery of a triple barrier that prevents cells from becoming cancerous
Universitat Autonoma de Barcelona researchers have identified for the first time a triple mechanism that stops mitosis when the integrity of the chromosomes is threatened. The activation of any of the three control pathways blocks the process that could lead to a malignant transformation. The study has been published in PLOS Genetics.

Contact: David Quintana
Universitat Autonoma de Barcelona

Public Release: 18-Sep-2015
Oral Oncology
Imaging method has potential to stratify head and neck cancer patients
Manchester researchers have identified a potential new way to predict which patients with head and neck cancer may benefit most from chemotherapy.

Contact: Jamie Brown
University of Manchester

Public Release: 18-Sep-2015
Molecular Oncology
Western University hopes to use artificial intelligence to improve breast cancer patient outcomes
Western University researchers are working on a way to use artificial intelligence to predict a patient's response to two common chemotherapy medications used to treat breast cancer -- paclitaxel and gemcitabine. Peter Rogan, Ph.D., and a team of researchers, including Stephanie Dorman, Ph.D., and Katherina Baranova, B.M.Sc., at Western's Schulich School of Medicine & Dentistry, are hoping to one day remove the guesswork from breast cancer treatment with this technique.

Contact: Tristan Joseph
519-661-2111 x80387
University of Western Ontario

Public Release: 17-Sep-2015
Surgical Clinics of North America
New prostate cancer screening review article advocates for active surveillance
In the wake of changing guidelines related to prostate cancer screening, a newly published review article out of University Hospitals Case Medical Center's Seidman Cancer Center in Cleveland provides important guidance about the prostate specific antigen test. The peer-reviewed article, titled Prostate Cancer Screening and the Associated Controversy, was published in the October issue of Surgical Clinics of North America.

Contact: Alicia Reale
University Hospitals Case Medical Center

Public Release: 17-Sep-2015
The Breast
Study finds high proportion of advanced breast cancers in sub-Saharan Africa
In one of the first studies of its kind, a new report finds a large majority of breast cancers in Cote d'Ivoire and Republic of Congo are detected only after they've become advanced.
The African Cancer Registry Network

Contact: David Sampson
American Cancer Society

Public Release: 17-Sep-2015
Clinical Epigenetics
Research discovery leads to potential diagnostic for assessing breast cancer recurrence
Every woman successfully treated for breast cancer lives with the knowledge that it could come back. New research published today in the journal Clinical Epigenetics may lead to a simple blood test to determine the risk of such recurrence, or the cancer invading other organs such as the lungs, bone or brain. Such a test would have profound implications for improving the future treatment of women with all types of breast cancer.
Marilyn B. Gula Mountains of Hope Foundation and SmartPractice

Contact: Steve Yozwiak
The Translational Genomics Research Institute

Public Release: 17-Sep-2015
Vaccine clears some precancerous cervical lesions in clinical trial
Scientists have used a genetically engineered vaccine to successfully eradicate high-grade precancerous cervical lesions in nearly one-half of women who received the vaccine in a clinical trial. The goal, say the scientists, was to find nonsurgical ways to treat precancerous lesions caused by HPV.
Inovio Pharmaceuticals Inc.

Contact: Vanessa Wasta
Johns Hopkins Medicine

Public Release: 17-Sep-2015
Journal of Clinical Oncology
Genomic differences between breast cancers of African American and white women identified
A study from investigators at the Massachusetts General Hospital Cancer Center has, for the first time, identified genomic differences between the breast tumors of African American and white women, differences that could contribute to the recognized differences in recurrence rate and survival.
Jerry Younger Grant for Clinical and Translational Breast Cancer Research

Contact: Katie Marquedant
Massachusetts General Hospital

Public Release: 17-Sep-2015
Physical Review X
Network control: Letting noise lead the way
Northwestern University researchers leverage randomness in a new computational approach to keep cells healthy.
NIH/National Cancer Institute, National Science Foundation

Contact: Megan Fellman
Northwestern University

Public Release: 17-Sep-2015
Journal of Nuclear Medicine
Molecular imaging study reveals improved detection of early recurrent prostate cancer
A recently developed drug was significantly better at detecting recurring prostate cancer in early stages, in research published in the August 2015 issue of The Journal of Nuclear Medicine.

Contact: Kimberly Brown
Society of Nuclear Medicine

Showing releases 1026-1050 out of 1291.

<< < 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 > >>

  Search News Releases


Featured Multimedia